[1] De Felice M, Di Lauro R. Thyroid development and its disorders:genetics and molecular mechanisms. Endocr Rev, 2004, 25(5):722-746.
[2] Eustatia-Rutten CF, Smit JW, Romijn JA, et al. Diagnostic value of thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf), 2004, 61(1):61-74.
[3] Whitley Pal, Ain KB. Thyroglobuhn:a specific serum marker for the management of thyroid carcinoma. Clin Lab Med, 2004, 24(1):29-47.
[4] Feldt-Rasmussen U, Schlumberger M. European interlaboratory comparison of serum thyroglobulin measurement. J Endocrinol Invest, 1988, 11(3):175-151.
[5] Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for lowrisk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab, 2003, 88(4):1433-1441.
[6] Pellegriti G, Scollo C, Regalbuto C, et al. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clin Endoerinol (Off), 2003, 58(5):556-561.
[7] Ehom A, Elnagar B, Elbagir M, et al. Thymoglobulin in serum as an indicator of iodine status during pregnancy. Scand J Clin Lab Invest, 2000, 60(1):1-7.
[8] Wagner K, Arciaga R, Siperstein A, et al. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology:diagnostic synergy for detecting thyroid cancer. J Clin Endocrinol Metab, 2005, 90(4):1921-1924.
[9] Bellantone R, Lombardi CP, Bossola M, et al. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type:results of a prospective study. Cancer, 2001, 92(9):2273-2279.
[10] Karavitaki N, Lembessis P, Tzanela M, et al. Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy. Anticancer Res, 2005, 25(4):3135-3142.
[11] Chinnappa P, Taguba L, Arciaga R, et al. Detection of thyralropinreceptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease:sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab, 2004, 89(8):3705-3709.
[12] Elisei R, Vivaldi A, Agate L, et al. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab, 2004, 89(1):53-39.
[13] Shlossberg AH, Jacobson JC, Ibbertson HK. Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endoerinol (0xf), 1979, 10(1):17-27.
[14] Heemstra KA, Liu YY, Stokkel M, et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrino (0xf), 2007, 66(1):58-64.
[15] Hishinuma A, Fukata S, Kakudo K, et al. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid, 2005, 15(9):1079-1084.
[16] Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003, 13(1):3.